ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Allarity Therapeutics Inc

Allarity Therapeutics Inc (ALLR)

0.7892
0.0225
( 2.93% )
Updated: 10:05:58

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
0.7892
Bid
0.783
Ask
0.7892
Volume
1,600,460
0.75 Day's Range 0.80
0.71 52 Week Range 14,656.00
Market Cap
Previous Close
0.7667
Open
0.78
Last Trade
66
@
0.7892
Last Trade Time
10:06:16
Financial Volume
$ 1,245,864
VWAP
0.778441
Average Volume (3m)
3,256,184
Shares Outstanding
6,178,892
Dividend Yield
-
PE Ratio
-0.24
Earnings Per Share (EPS)
-3.3
Revenue
-
Net Profit
-20.42M

About Allarity Therapeutics Inc

Allarity Therapeutics Inc is a clinical-stage, precision medicine company. Allarity Therapeutics Inc is a clinical-stage, precision medicine company.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
1970
Allarity Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ALLR. The last closing price for Allarity Therapeutics was $0.77. Over the last year, Allarity Therapeutics shares have traded in a share price range of $ 0.71 to $ 14,656.00.

Allarity Therapeutics currently has 6,178,892 shares outstanding. The market capitalization of Allarity Therapeutics is $4.94 million. Allarity Therapeutics has a price to earnings ratio (PE ratio) of -0.24.

ALLR Latest News

Allarity Therapeutics Announces that All Series A Preferred and All Variable Priced Warrants have Converted to Common Stock

- Conversions Eliminate All Variable Priced Derivative Securities - Conversions Eliminate Any Market Overhang from Warrants - Series A Preferred and Warrant Conversions were Investor Initiated...

Allarity Therapeutics Exceeds Nasdaq’s Minimum Equity Requirement; Requests Voluntarily Withdrawal of Form S-1

- Stockholders’ equity significantly surpasses the $2.5 million minimum required by Nasdaq - Company is to seek Nasdaq’s formal confirmation of compliance with equity requirements under the...

Allarity Therapeutics’ Stenoparib Shows Clear Clinical Benefit and Achieves Significant Milestone with Early Conclusion of Phase 2 Trial in Advanced Ovarian Cancer

Boston (May 2, 2024)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, today...

Allarity Therapeutics Regains Compliance with NASDAQ Minimum Bid Price Requirement

Boston (April 29, 2024) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-2.2508-74.03947368423.043.460.71271424401.11953694CS
4-2.4208-75.41433021813.2140.7183409001.27403288CS
12-7.2108-90.13588.80.7132561841.70526879CS
26-9.1108-92.02828282839.922.20.7122760884.85454171CS
52-13445.6108-99.994130771113446.4146560.7116838931427.47260696CS
1562220701.46045-100.000035538-2220700.67125123520-1484398.551871523980-19318.4087147CS
2602220701.46045-100.000035538-2220700.67125123520-1484398.551871523980-19318.4087147CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CPOPPop Culture Group Company Ltd
$ 3.3699
(98.23%)
53.37M
SEZLSezzle Inc
$ 75.56
(68.89%)
284.56k
EMBCEmbecta Corporation
$ 14.22
(38.46%)
786.3k
NTBLNotable Labs Ltd
$ 1.61
(35.29%)
2.08M
CCSIConcensus Cloud Solutions Inc
$ 17.64
(33.33%)
157.81k
EMKREMCORE Corporation
$ 1.1101
(-61.72%)
2.12M
TIVCTivic Health Systems Inc
$ 0.5245
(-60.86%)
4.91M
CDLXCardlytics Inc
$ 8.26
(-43.42%)
3.81M
CTMXCytomX Therapeutics Inc
$ 2.4591
(-41.31%)
13.41M
RAPTRAPT Therapeutics Inc
$ 5.16
(-35.34%)
1.61M
GWAVGreenwave Technology Solutions Inc
$ 0.0702
(20.83%)
106.13M
CPOPPop Culture Group Company Ltd
$ 3.3699
(98.23%)
53.37M
SGDSafe and Green Development Corporation
$ 0.79
(27.42%)
42.67M
SQQQProShares UltraPro Short QQQ
$ 10.755
(0.14%)
20.47M
PLUGPlug Power Inc
$ 2.60
(3.17%)
19.99M

ALLR Discussion

View Posts
TheOTCstocksGuy TheOTCstocksGuy 1 day ago
Pure trash!! Just going to continue to sink!!
👍️0
wickerman wickerman 2 days ago
$ALLR more massive dilution from this scam how bullish.

Patience there's a nice bounce coming from .09 to 11
👍️0
eyeownu eyeownu 3 days ago
$ALLR atm will be off soon. We filed the Prior Prospectus to register the offer and sale of our common stock, par value $0.0001 per share, from time to time pursuant to the terms of that certain At-The-Market Issuance Sales Agreement (the “Sales Agreement”), between Ascendiant Capital Markets, LLC (the “Sales Agent”) and us. Prior to the date of this prospectus supplement, we were subject to General Instruction I.B.6 of Form S-3 as a result of our public float being less than $75.0 million, which limited the maximum amount of common stock we could sell under the Sales Agreement to the amount set forth in the Prior Prospectus (up to $18,000,000). On May 2, 2024, our public float increased above $75.0 million and, as a result, we are not subject to the limitations contained in General Instruction I.B.6 of Form S-3 as of the date of this prospectus supplement.



On May 6, 2024, we amended the Sales Agreement to, among other things, increase the total amount of common stock that we may offer and sell under the sales agreement to $20,000,000 (which amount includes shares we have already sold pursuant to the Sales Agreement prior to the date of this prospectus supplement), subject to certain limitations in the Sales Agreement, as amended. As of May 2, 2024, we have sold an aggregate of 10,835,422 shares of our common stock pursuant to the Sales Agreement for gross proceeds of 16,054,081 (the “Gross Proceeds”).
👍️0
goldforbrains goldforbrains 3 days ago
Trading at 4.5 cents on a pre rollback basis. Geez.
👍️0
Monksdream Monksdream 3 days ago
What a surprise
Will it grow legs after the reverse split
👍️0
axelvento axelvento 3 days ago
announced its intention to seek formal confirmation from Nasdaq regarding its compliance with the equity requirements outlined in Rule 5550(b)(1) of the exchange’s regulations. Currently its stockholders’ equity is significantly above the $2.5 million minimum required by Nasdaq Listing Rule 5550(b)(1).
👍️0
TheOTCstocksGuy TheOTCstocksGuy 6 days ago
Called it….right back under $1!! Just an absolute POS cluttering up the market!!
👍️0
Monksdream Monksdream 6 days ago
ALLR new 52 week low
👍️0
surf1944 surf1944 6 days ago
https://stockcharts.com/h-sc/ui?s=allr&p=D&yr=0&mn=6&dy=0&id=p38090673899

https://www.barchart.com/stocks/quotes/allr/technical-chart?plot=CANDLE&volume=total&data=DO&density=M&pricesOn=1&asPctChange=0&logscale=1&indicators=BBANDS(20,2);SMA(13);PTP(50);ADX(14);SMA(50);SMACD(12,26,9);RSI(14,100);ACCUM;STOSL(14,3)&sym=CNNA&grid=1&height=500&studyheight=100

https://www.barchart.com/stocks/quotes/allr/opinion

https://finance.yahoo.com/quote/allr/

ALLR worth a trade at this level!
$1.20
👍️0
TIMGZ TIMGZ 7 days ago
The information in this prospectus is not complete and may be changed. The selling stockholders named in this prospectus may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and the selling stockholders named in this prospectus are not soliciting offers to buy these securities in any jurisdiction where the offer or sale is not permitted.

Subject to completion, dated April 30, 2024

PROSPECTUS

Graphic

17,580,566 SHARES

COMMON STOCK
👍️0
Acehole Acehole 7 days ago
Shorts win again

No mercy for longs. Either from shorts or from management.
👍️0
TheOTCstocksGuy TheOTCstocksGuy 7 days ago
Nah it’s done and over. Closing red
👍️0
TheOTCstocksGuy TheOTCstocksGuy 7 days ago
More trash cluttering up the market! What a POS
👍️0
Acehole Acehole 7 days ago
lol looks like it’s gonna finish in the RED
👍️0
Acehole Acehole 7 days ago
What a piece of shit. Everyone got the news they were waiting for and this Terd couldn’t even hold $2
👍️0
TrendTrade2016 TrendTrade2016 1 week ago
ALLR...POST SPLIT POP COMNG IN!!!!!
👍️0
Awl416 Awl416 1 week ago
Allarity Therapeutics’ Stenoparib Shows Clear Clinical Benefit and Achieves Significant Milestone with Early Conclusion of Phase 2 Trial in Advanced Ovarian Cancer
👍️0
Monksdream Monksdream 1 week ago
ALLR new 52 week low
👍️0
Monksdream Monksdream 3 weeks ago
You’re good at translating corporate speak
ALLR new 52 lo
👍️0
Monksdream Monksdream 3 weeks ago
ALLR new 52 lo
👍️0
Acehole Acehole 3 weeks ago
"In addition, the company has entered into negotiations with key stakeholders, including warrant holders, to adjust the terms and conditions to make future capital raising more amenable, as well as negotiations to reduce other major liabilities. Finally, the Company has already started raising new equity by utilizing its existing ATM and expects to take further action so Allarity can meet the $2,500,000 equity requirement on the May 14, 2024 target date."

They plan on CONTINUING TO DUMP SHARES on the open market and DILUTING their shareholders with no end in sight.

"Our goal is to ensure that we can continue our development of stenoparib, strongly encouraged by the significant early data we have received so far from our ongoing monotherapy trial in advanced ovarian cancer."

In other words stenoparib is still not ready for phase 3. They are going to have to chemically modify it to try to improve it which means repeating phase 1 and phase 2 trials. They are going to need a A LOT more time and money and there is no guarantee at all that they can get it modified to the point it needs to be at.

This is a TOXIC investment. If there happens to be a pump, sell for what you can and get out. They are just going to continue with the reverse splits followed by dilution for the foreseeable future as they have no revenue, no product, and thomas jackass jensen needs to collect his handsome salary.
👍️0
BooDog BooDog 3 weeks ago
Good call imo. I was just surfing around Monks new 52 wk low calls. There's usually a good reason for that. Multiple RS's and offerings at the wrong time.

GL
👍️0
Acehole Acehole 3 weeks ago
Most pharmaceutical R&D companies are high risk poorly run trash investments. Even by those standards ALLR is relative garbage. This is literally a bottom of the barrel company running purely off of lies and deceit by management. I’ve been investing for 15 years and have never see a company destroy their investors this aggressively and this quickly. Despite diluting us into oblivion, the market cap is again under $1 million as of today. Stenoparib clinical data is obviously showing that it is either not safe or not effective, otherwise this would not be happening. ALLR is DONE. Do NOT invest.
👍️ 1
Acehole Acehole 4 weeks ago
Nothing to be bullish about here. This company is now a one trick pony. If stenoparib fails they are done. I'm thinking if stenoparib was doing as good as their last press release indicated then the price would be appreciating. Tread carefully as investing in this company is a gamble and I personally do not trust management.
👍️0
MetaMonster MetaMonster 4 weeks ago
New blood soaking up the float, is only a matter of time before we roar
👍️0
Money hunt Money hunt 4 weeks ago
Dirty short rats are going to get it up the ass power hour and TGIF
👍️0
Money hunt Money hunt 4 weeks ago
wrong answer as usual!!! Here come the Pharma bulls!!
👍️0
Monksdream Monksdream 4 weeks ago
Precious metals have the MOJO at present
👍️0
Money hunt Money hunt 4 weeks ago
The dip is in dude!! Let’s see if this baby has power!!!
👍️0
Money hunt Money hunt 4 weeks ago
FDA Green light will send this flying in outer space
👍️0
Money hunt Money hunt 4 weeks ago
No kidding!!! HiUge Short squeeze is imminent All holding for lift -off
👍️0
Monksdream Monksdream 4 weeks ago
ALLR no 1 on the Barchart 100
👍️0
Monksdream Monksdream 4 weeks ago
Early Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?orderBy=percentChange&orderDir=desc
👍️0
tw0122 tw0122 4 weeks ago
Hit it 200k float
👍️0
Monksdream Monksdream 4 weeks ago
ALLR new 52 lo
👍️0
2020trader 2020trader 4 weeks ago
down 13% today , expecting lower
👍️0
2020trader 2020trader 1 month ago
DOWN 3% TODAY, EXPECTING LOWER
👍️0
DK11 DK11 1 month ago
Trading Halt at 7:50 pm wonder if it has anything to do with the R/S
👍️0
Triple nickle Triple nickle 1 month ago
Rs april 9 th 1/20
👍️0
Monksdream Monksdream 1 month ago
ALLR new 52 lo
👍️0
stock1ace1 stock1ace1 1 month ago
Why ?
👍️0
Triple nickle Triple nickle 1 month ago
Buy and hold,period
👍️0
Triple nickle Triple nickle 1 month ago
Picking up the dips
👍️0
Monksdream Monksdream 2 months ago
ALLR new 52 week low
👍️0
Monksdream Monksdream 3 months ago
ALLR new 52 week low
👍️0
Invest-in-America Invest-in-America 5 months ago
ALLR: Any time, Dude!!

PS: If I myself were running the USA, every 'Women' over 16 would be REQUIRED & AUTHORIZED to pack-a-firearm --- concealed, or otherwise --- and THEN see if America's MEN would still MESS with them!!! I.e., not merely regarding Wall Street STOCK issues regarding Women.
👍️0
WiseYoda WiseYoda 5 months ago
Thanks for the feedback
👍️0
Invest-in-America Invest-in-America 5 months ago
ALLR: As I have noted on several occasions across the iHub platform, WOMENS issues simply do NOT gain much 'traction' on Wall Street, Dude. GOOD LUCK, if you nevertheless grab this one. (E.g., I did well on my @INST gamble today --- a Breast Cancer PR routine --- but had to DUMP it quickly into the Open Market in order to get the minimal profit I wanted.)
👍️0
WiseYoda WiseYoda 5 months ago
52 week high $1852? Holy moly….
👍️0
WiseYoda WiseYoda 5 months ago
*know
👍️0

Your Recent History

Delayed Upgrade Clock